赛升药业股价震荡，机构关注度低，主业盈利待改善

Group 1 - The stock price of Sai Sheng Pharmaceutical (300485) showed a fluctuating trend in the past seven trading days, closing at 11.26 yuan on February 13, down 0.79% from 11.35 yuan on February 6, with a range of 7.41% [1] - Trading activity increased initially, with a transaction amount exceeding 116 million yuan on February 10 (turnover rate of 3.64%), but decreased to 40.48 million yuan on February 13 (turnover rate of 1.31%) [1] - On February 13, there was a net outflow of 1.5279 million yuan in main funds, continuing the recent trend of net outflows, indicating a strong wait-and-see sentiment among short-term investors [1] Group 2 - Institutional attention on Sai Sheng Pharmaceutical is low, with no new research or rating changes recently; the latest market consensus as of February 14 shows a neutral rating at 100% [2] - The earnings forecast remains based on 2024 data, with an expected earnings per share of -0.14 yuan [2] - The company faces challenges in its core cardiovascular drug business due to intensified industry competition and insufficient R&D conversion efficiency, although it is expected to turn profitable by 2025, the quality of earnings relies on investment income, and the core profitability has not significantly improved [2]